BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22069641)

  • 1. On the interaction of Clostridium perfringens enterotoxin with claudins.
    Veshnyakova A; Protze J; Rossa J; Blasig IE; Krause G; Piontek J
    Toxins (Basel); 2010 Jun; 2(6):1336-56. PubMed ID: 22069641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins.
    Veshnyakova A; Piontek J; Protze J; Waziri N; Heise I; Krause G
    J Biol Chem; 2012 Jan; 287(3):1698-708. PubMed ID: 22128179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for
    Vecchio AJ; Rathnayake SS; Stroud RM
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins.
    Mitchell LA; Koval M
    Toxins (Basel); 2010 Jul; 2(7):1595-611. PubMed ID: 22069652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier.
    Zhang J; Ni C; Yang Z; Piontek A; Chen H; Wang S; Fan Y; Qin Z; Piontek J
    Exp Dermatol; 2015 Aug; 24(8):605-10. PubMed ID: 25869230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin.
    Shrestha A; McClane BA
    mBio; 2013 Jan; 4(1):. PubMed ID: 23322640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium perfringens enterotoxin interacts with claudins via electrostatic attraction.
    Kimura J; Abe H; Kamitani S; Toshima H; Fukui A; Miyake M; Kamata Y; Sugita-Konishi Y; Yamamoto S; Horiguchi Y
    J Biol Chem; 2010 Jan; 285(1):401-8. PubMed ID: 19903817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of Clostridium perfringens enterotoxin with receptor claudins.
    Shrestha A; Uzal FA; McClane BA
    Anaerobe; 2016 Oct; 41():18-26. PubMed ID: 27090847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, structure, and mechanism of synthetic antibodies that target claudin and Clostridium perfringens enterotoxin complexes.
    Orlando BJ; Dominik PK; Roy S; Ogbu CP; Erramilli SK; Kossiakoff AA; Vecchio AJ
    J Biol Chem; 2022 Sep; 298(9):102357. PubMed ID: 35952760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of Claudin-Made Tight Junction Barriers by
    Ogbu CP; Roy S; Vecchio AJ
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin-Targeted Suicide Gene Therapy for Claudin-Overexpressing Tumor Cells by Using Modified Clostridium perfringens Enterotoxin (CPE).
    Beier LS; Piontek J; Piontek A; Protze J; Kobelt D; Walther W
    Methods Mol Biol; 2022; 2521():173-188. PubMed ID: 35732998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5.
    Protze J; Eichner M; Piontek A; Dinter S; Rossa J; Blecharz KG; Vajkoczy P; Piontek J; Krause G
    Cell Mol Life Sci; 2015 Apr; 72(7):1417-32. PubMed ID: 25342221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Method to Prepare Claudin-Modulating Recombinant Proteins.
    Tachibana K; Kondoh M
    Methods Mol Biol; 2020; 2109():251-260. PubMed ID: 31471875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis of
    Ogbu CP; Kapoor S; Vecchio AJ
    Toxins (Basel); 2023 Oct; 15(11):. PubMed ID: 37999500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3.
    Winkler L; Gehring C; Wenzel A; Müller SL; Piehl C; Krause G; Blasig IE; Piontek J
    J Biol Chem; 2009 Jul; 284(28):18863-72. PubMed ID: 19429681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-9 structures reveal mechanism for toxin-induced gut barrier breakdown.
    Vecchio AJ; Stroud RM
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17817-17824. PubMed ID: 31434788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein.
    Fujita K; Katahira J; Horiguchi Y; Sonoda N; Furuse M; Tsukita S
    FEBS Lett; 2000 Jul; 476(3):258-61. PubMed ID: 10913624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
    Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
    Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.
    Robertson SL; Smedley JG; McClane BA
    Infect Immun; 2010 Jan; 78(1):505-17. PubMed ID: 19884339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.